CasLoc logo
All Cases PTAB Litigations UPC Oppositions

In Re: Amerisourcebergen Drug Corporation

1:24-mc-00461

Overview

Case Number 1:24-mc-00461
Filing Date 2024-09-26
Status Terminated
Termination Date 2024-10-03
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action Motion to Compel
Jury Demand None

Parties

Petitioner

Takeda Pharmaceuticals U.S.A., Inc. Operating Company

Represented By

1 Attorneys Listed

Alan Richard Silverstein

Connolly Gallagher LLP

Tel: +1 (302) 757-7322

1201 N. Market St., 20th Floor

Respondent

Amerisourcebergen Drug Corporation NPE (Individual / Inventor)

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

No Co-Pending Disputes Detected in Current Index

There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.

Patents Involved

No asserted patent numbers detected in initial docket filings yet.

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

2

Dispositive

0

Granted

0

Denied

0

Pending / Review

2

Motions by Category

Motion to Compel Discovery 2

Key Dispositive Motions & Rulings

Motion to Compel Discovery Pending / Under Review
MOTION to Compel Third Party Amerisourcebergen Drug Corporation, D.B.A. Cencora, Inc. to Comply with the Deposition Subpoena (Filing Fee Paid. Receipt No. ADEDC...
Entry #1 • 2024-09-26 Document →
Motion to Compel Discovery Pending / Under Review
OPENING BRIEF in Support of 1 Motion to Compel Third Party Amerisourcebergen Drug Corporation, D.B.A. Cencora, Inc. to Comply with the Deposition Subpoena - fil...
Entry #2 • 2024-09-26 Document →

Docket Entries

(15 total)
Motion to Compel Discovery Pending / Under Review

MOTION to Compel Third Party Amerisourcebergen Drug Corporation, D.B.A. Cencora, Inc. to Comply with the Deposition Subpoena (Filing Fee Paid. Receipt No. ADEDC-4508342) - filed by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: # 1 Exhibits 1-5, # 2 Proposed Order, # 3 Civil Cover Sheet)(jfm) Modified on 9/26/2024 (nms). (Entered: 09/26/2024)

Entry #1 • 2024-09-26
1
Motion to Compel Discovery Pending / Under Review

OPENING BRIEF in Support of 1 Motion to Compel Third Party Amerisourcebergen Drug Corporation, D.B.A. Cencora, Inc. to Comply with the Deposition Subpoena - filed by Takeda Pharmaceuticals U.S.A., Inc. Answering Brief/Response due date per Local Rules is 10/10/2024. (jfm) Modified on 9/26/2024 (nms). (Entered: 09/26/2024)

Entry #2 • 2024-09-26
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceutical Company Limited, Other Affiliate Takeda Pharmaceuticals International AG for Takeda Pharmaceuticals U.S.A., Inc. filed by Takeda Pharmaceuticals U.S.A., Inc. (jfm) (Entered: 09/26/2024)

Entry #3 • 2024-09-26
1

Summons Issued as to Amerisourcebergen Drug Corporation. (jfm) (Entered: 09/26/2024)

Entry #4 • 2024-09-26
1

Remark: Case Submitted for Routine Judicial Assignment. (jfm)

Entry #5 • 2024-09-26
1
No Actions

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc